Parabilis Medicines
Principal Associate Scientist, Biology
Cambridge · Principal
Sponsorship not specified$108k-$128kDetected 40 days ago
Node.jsPharmacologyqPCRCRISPRMolecular BiologyResearchWestern BlottingCommunicationCollaborationMentoring
About the role
- The company has pioneered a new class of alpha-helical peptides - Helicons™ - capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines.
- Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications.
- Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.
Responsibilities
- Design and execute target engagement and mechanism-of-action studies to characterize novel therapeutic candidates
- Develop cell-based assays (e.g., NanoBRET, HiBiT, AlphaLISA, HTRF) from conceptualization and proof-of-concept through to validated implementation in collaboration with internal or external cell pharmacology team
- Perform and interpret supporting assays including qPCR, Western blotting, immunoprecipitation, and pulldown assays
- Independently manage experimental workflows, anticipate technical challenges, and drive projects to completion
- Maintain high standards of data integrity, documentation, and experimental reproducibility
- Deep expertise in developing and executing cell-based assays (e.g., NanoBRET, HiBiT, AlphaLISA, HTRF)
- Demonstrated ability to independently design, execute, and interpret experiments
Requirements
- Proficiency in molecular and biochemical techniques including qPCR, Western blotting, immunoprecipitation, and pulldown assays
- Experience with cell line engineering (CRISPR/Cas9, viral expression systems)
- Ability to critically evaluate complex datasets, resolve discrepancies, and communicate clear conclusions to cross-functional stakeholders
- Intellectual curiosity, proactively identifying opportunities to deepen expertise or explore new approaches
Nice to have
- Experience with induced proximity or targeted protein degradation approaches
- Experience in oncology drug discovery
- We're inventing a new class of medicines-one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug.
- Our work requires us to be curious, humble and adaptable.
- In(ter)dependent.
- Patient-focused.
- We're All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.
- Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients.
Compensation
- The base salary range for this position is $108,000-$128,000 per year, depending on experience, qualifications, and internal practices.
- Parabilis's total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees' overall well-being.
Benefits
- Education & Experience
- The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.
Company info
- We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
- Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
Apply directly at Parabilis Medicines →Create a free account for alerts like thisView Parabilis Medicines immigration profile
This listing is sourced directly from Parabilis Medicines's careers page and normalized into a canonical job model.